Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Atmeksi. Always confirm against the full prescribing information.
100 interactions
Acetazolamide
The risk or severity of CNS depression can be increased when Methocarbamol is combined with Acetazolamide.
Level 2 evidence
Alfentanil
The risk or severity of CNS depression can be increased when Methocarbamol is combined with Alfentanil.
Level 2 evidence
Almotriptan
The risk or severity of CNS depression can be increased when Methocarbamol is combined with Almotriptan.
Level 2 evidence
Alosetron
The risk or severity of CNS depression can be increased when Methocarbamol is combined with Alosetron.
Level 2 evidence
Alprazolam
The risk or severity of CNS depression can be increased when Alprazolam is combined with Methocarbamol.
Level 2 evidence
Amisulpride
The risk or severity of CNS depression can be increased when Methocarbamol is combined with Amisulpride.
Level 2 evidence
Amitriptyline
The risk or severity of CNS depression can be increased when Amitriptyline is combined with Methocarbamol.
Level 2 evidence
Amobarbital
The risk or severity of CNS depression can be increased when Methocarbamol is combined with Amobarbital.
Level 2 evidence
Amoxapine
The risk or severity of CNS depression can be increased when Methocarbamol is combined with Amoxapine.
Level 2 evidence
Apomorphine
The risk or severity of CNS depression can be increased when Methocarbamol is combined with Apomorphine.
Level 2 evidence
Aripiprazole
The risk or severity of CNS depression can be increased when Methocarbamol is combined with Aripiprazole.
Level 2 evidence
Aripiprazole lauroxil
The risk or severity of CNS depression can be increased when Methocarbamol is combined with Aripiprazole lauroxil.
Level 2 evidence
Enter your NPI to unlock 3 major interactions for Atmeksi
Atmeksi (Methocarbamol) has 278 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Atmeksi (Methocarbamol) has 8 major, 262 moderate, and 8 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Atmeksi. Always confirm against the full prescribing information.